Browsing by Author Novartis Pharmaceuticals Corporation

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)
18-Sep-2015Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: A systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient dataElizabeth A. Ashley; Francesca Aweeka; Karen I. Barnes; Quique Bassat; Steffen Borrmann; Prabin Dahal; Timothy M.E. Davis; Mey Bouth Denis; Abdoulaye A. Djimde; Jean François Faucher; Blaise Genton; Philippe J. Guérin; Kamal Hamed; Eva Maria Hodel; Liusheng Huang; Vincent Jullien; Harin A. Karunajeewa; Jean René Kiechel; Poul Erik Kofoed; Gilbert Lefèvre; Niklas Lindegardh Lindegardh; Andreas Mårtensson; Mayfong Mayxay; Rose Mcgready; Clarissa Moreira; Paul N. Newton; Billy E. Ngasala; Francois Nosten; Christian Nsanzabana; Sunil Parikh; Patrice Piola; Ric N. Price; Pascal Ringwald; Lars Rombo; Birgit Schramm; Carol Hopkins Sibley; Kasia Stepniewska; Joel Tarning; Johan Ursing; Michele Van Vugt; Nicholas J. White; Lesley J. Workman; Philippe Deloron; Kevin Marsh; Shoklo Malaria Research Unit; Mahidol University; University of California, San Francisco; WorldWide Antimalarial Resistance Network (WWARN); University of Cape Town; Instituto de Salud Global de Barcelona; Centro de Investigação em Saúde de Manhiça (CISM); Wellcome Trust Research Laboratories Nairobi; Universitat Tubingen; Nuffield Department of Clinical Medicine; University of Western Australia; IRD Institut de Recherche pour le Developpement; Universite Paris Descartes; National Center for Parasitology; Organisation Mondiale de la Sante; University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology; Hopital Jean Minjoz; Swiss Tropical and Public Health Institute (Swiss TPH); Centre Hospitalier Universitaire Vaudois; Novartis Pharmaceuticals Corporation; Liverpool School of Tropical Medicine; Drugs for Neglected Diseases Initiative; Syddansk Universitet; Kolding Sygehus; Novartis International AG; Kenya Medical Research Institute; Karolinska Institutet; Wellcome Trust; Muhimbili University of Health and Allied Sciences; Yale Schools of Public Health and Medicine; Department of Clinical Pharmacology; Institut Pasteur de Madagascar; Menzies School of Health Research; Uppsala Universitet; Epicentre; University of Washington, Seattle; University of Amsterdam
22-Sep-2015Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: An individual patient data meta-analysisSalim Abdulla; Elizabeth A. Ashley; Quique Bassat; Delia Bethell; Anders Björkman; Steffen Borrmann; Umberto D’Alessandro; Prabin Dahal; Nicholas P. Day; Mahamadou Diakite; Abdoulaye A. Djimde; Arjen M. Dondorp; Socheat Duong; Michael D. Edstein; Rick M. Fairhurst; M. Abul Faiz; Catherine Falade; Jennifer A. Flegg; Carole Fogg; Raquel Gonzalez; Brian Greenwood; Philippe J. Guérin; Jean Paul Guthmann; Kamal Hamed; Tran Tinh Hien; Ye Htut; Elizabeth Juma; Pharath Lim; Andreas Mårtensson; Mayfong Mayxay; Olugbenga A. Mokuolu; Clarissa Moreira; Paul Newton; Harald Noedl; Francois Nosten; Bernhards R. Ogutu; Marie A. Onyamboko; Seth Owusu-Agyei; Aung Pyae Phyo; Zul Premji; Ric N. Price; Sasithon Pukrittayakamee; Michael Ramharter; Issaka Sagara; Youry Se; Seila Suon; Kasia Stepniewska; Stephen A. Ward; Nicholas J. White; Peter A. Winstanley; Ifakara Health Institute; Nuffield Department of Clinical Medicine; Mahidol University; Centro de Investigação em Saúde de Manhiça; Instituto de Salud Global de Barcelona; Armed Forces Research Institute of Medical Sciences, Thailand; Karolinska University Hospital; Kenya Medical Research Institute; Magdeburg University School of Medicine; Prins Leopold Instituut voor Tropische Geneeskunde; Medical Research Council Unit; WorldWide Antimalarial Resistance Network (WWARN); University of Bamako; National Center for Parasitology, Entomology and Malaria Control; Australian Army Malaria Institute; National Institute of Allergy and Infectious Diseases; Malaria Research Group and Dev Care Foundation; University of Ibadan; Monash University; University of Portsmouth; Centre de Recerca en Salut Internacional de Barcelona (CRESIB); London School of Hygiene & Tropical Medicine; Epicentre; Novartis Pharmaceuticals Corporation; University of Oxford; Department of Medical Research; Karolinska Institutet; Uppsala Universitet; Mahosot Hospital; University of Health Sciences; University of Ilorin; Medizinische Universitat Wien; Kinshasa School of Public Health; Kintampo Health Research Centre; Muhimbili University of Health and Allied Sciences; Menzies School of Health Research; Universitat Tubingen; Centre de Recherches Médicales de Lambaréné; University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology; Armed Forces Research Institute of Medical Sciences; Liverpool School of Tropical Medicine; Warwick Medical School
7-Sep-2015Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: A literature review and meta-analysis of individual patient dataSalim Abdulla; Ishag Adam; George O. Adjei; Martin A. Adjuik; Bereket Alemayehu; Richard Allan; Emmanuel Arinaitwe; Elizabeth A. Ashley; Mamadou S. Ba; Hubert Barennes; Karen I. Barnes; Quique Bassat; Elisabeth Baudin; Nicole Berens-Riha; Anders Björkman; François Bompart; Maryline Bonnet; Steffen Borrmann; Teun Bousema; Philippe Brasseur; Hasifa Bukirwa; Francesco Checchi; Prabin Dahal; Umberto D'Alessandro; Meghna Desai; Alassane Dicko; Abdoulaye A. Djimdé; Grant Dorsey; Ogobara K. Doumbo; Chris J. Drakeley; Stephan Duparc; Teferi Eshetu; Emmanuelle Espié; Jean François Etard; Abul M. Faiz; Catherine O. Falade; Caterina I. Fanello; Jean François Faucher; Babacar Faye; Oumar Faye; Scott Filler; Jennifer A. Flegg; Bakary Fofana; Carole Fogg; Nahla B. Gadalla; Oumar Gaye; Blaise Genton; Peter W. Gething; José P. Gil; Raquel González; Francesco Grandesso; Bryan Greenhouse; Brian Greenwood; Anastasia Grivoyannis; Philippe J. Guerin; Jean Paul Guthmann; Kamal Hamed; Sally Hamour; Simon I. Hay; Eva Maria Hodel; Georgina S. Humphreys; Jimee Hwang; Maman L. Ibrahim; Daddi Jima; Joel J. Jones; Vincent Jullien; Elizabeth Juma; Patrick S. Kachur; Piet A. Kager; Erasmus Kamugisha; Moses R. Kamya; Corine Karema; Ifakara Health Institute; University of Khartoum Faculty of Medicine; University of Ghana; INDEPTH Network; International Center for AIDS Care and Treatment Programs; MENTOR Initiative; Infectious Diseases Research Collaboration; Epicentre; Universite Cheikh Anta Diop; Centre MURAZ; French Foreign Affairs; WorldWide Antimalarial Resistance Network; University of Cape Town; Centro de Investigação em Saúde de Manhiça; Instituto de Salud Global de Barcelona; Ludwig-Maximilians-Universitat Munchen; Karolinska University Hospital; Sanofi S.A.; Kenya Medical Research Institute; Universitat Tubingen; German Centre for Infection Research; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen Medical Centre; Institut de Recherche pour le Developpement Dakar; Uganda Malaria Surveillance Project; WorldWide Antimalarial Resistance Network (WWARN); Nuffield Department of Clinical Medicine; Prins Leopold Instituut voor Tropische Geneeskunde; Medical Research Council Unit; Centers for Disease Control and Prevention; University of Bamako Faculty of Medicine, Pharmacy and Odonto-Stomatology; University of California, San Francisco; Medicines for Malaria Venture; Jimma University; IRD Centre de Montpellier; Mahidol University; University of Ibadan; IRD Institut de Recherche pour le Developpement; Universite Paris Descartes; Besançon University Medical Center; The Global Fund to Fight AIDS, Tuberculosis and Malaria; Monash University; Portsmouth Hospitals NHS Trust; Tropical Medicine Research Institute Sudan; National Institute of Allergy and Infectious Diseases; Swiss Tropical and Public Health Institute (Swiss TPH); Centre Hospitalier Universitaire Vaudois; University of Oxford; Karolinska Institutet; Faculdade de Ciencias, Universidade de Lisboa; Binghamton University State University of New York; University of Washington, Seattle; Institut de Veille Sanitaire; Novartis Pharmaceuticals Corporation; UCL; Wellcome Trust Centre for Human Genetics; National Institutes of Health, Bethesda; Liverpool School of Tropical Medicine; Centre de Recherche Médicale et Sanitaire; Federal Ministry of Health - Ethiopia; Ministry of Health and Social Welfare; Academic Medical Centre, University of Amsterdam; Catholic University of Health and Allied Sciences; Makerere University; Ministry of Health; Drugs for Neglected Diseases Initiative; Projecto de Saúde de Bandim; Kolding Sygehus; Centre de Recherches Médicales de Lambaréné; University of London; Médecins Sans Frontières; European & Developing Countries Clinical Trials Partnership; Federal Ministry of Health Sudan; Uppsala Universitet; University of Abomey-Calavi; University of Cocody; Institut Pasteur du Cambodge; Royal Tropical Institute - KIT; University of Calabar; Institute of Tropical Diseases Research and Prevention; Mbarara University of Science and Technology; Tropical Diseases Research Centre; Muhimbili University of Health and Allied Sciences; Institut de Recherche en Sciences de la Santé; Universite Marien Ngouabi
1-Mar-2011Clinical efficacy and safety evaluation of tailoring iron chelation practice in thalassaemia patients from Asia-Pacific: A subanalysis of the EPIC study of deferasiroxVip Viprakasit; Hishamshah Ibrahim; Shau Yin Ha; Phoebe Joy Ho; Chi Kong Li; Lee Lee Chan; Chang Fang Chiu; Pranee Sutcharitchan; Dany Habr; Gabor Domokos; Bernard Roubert; Hong Ling Xue; Donald K. Bowden; Kai Hsin Lin; Mahidol University; Kuala Lumpur Hospital; The University of Hong Kong; Royal Prince Alfred Hospital; Prince of Wales Hospital Hong Kong; University of Malaya Medical Centre; China Medical University Hospital Taichung; Chulalongkorn University; Novartis Pharmaceuticals Corporation; Novartis International AG; Novartis Asia Pacific Pharmaceuticals Pte Ltd; Monash Medical Centre; National Taiwan University Hospital
1-Nov-2006Efficacy and safety of the six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in adolescents and adults: A pooled analysis of individual patient data from randomized clinical trialsEdgar A. Mueller; Michele van Vugt; Wilhelm Kirch; Kim Andriano; Philip Hunt; Patricia Ibarra de Palacios; Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus; Mahidol University; University of Amsterdam; Novartis Pharmaceuticals Corporation; Novartis Horsham Research Centre; Novartis International AG
1-Jan-2013Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2Shinzaburo Noguchi; Norikazu Masuda; Hiroji Iwata; Hirofumi Mukai; Jun Horiguchi; Puttisak Puttawibul; Vichien Srimuninnimit; Yutaka Tokuda; Katsumasa Kuroi; Hirotaka Iwase; Hideo Inaji; Shozo Ohsumi; Woo Chul Noh; Takahiro Nakayama; Shinji Ohno; Yoshiaki Rai; Byeong Woo Park; Ashok Panneerselvam; Mona El-Hashimy; Tetiana Taran; Tarek Sahmoud; Yoshinori Ito; Osaka University; Osaka National Hospital; Aichi Cancer Center Hospital and Research Institute; National Cancer Center Hospital East; Gunma University Hospital; Prince of Songkla University; Mahidol University; Tokai University; Tokyo Metropolitan Komagome Hospital; Kumamoto University; Osaka Medical Center for Cancer and Cardiovascular Diseases; National Shikoku Cancer Center Hospital; Korea Cancer Center Hospital; National Kyushu Cancer Center; Sagara Hospital; Yonsei University College of Medicine; Novartis Pharmaceuticals Corporation; Cancer Institute Hospital of Japan Foundation for Cancer Research
22-Apr-2016Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: Results from the 2-year roadmap strategyTeerha Piratvisuth; Piyawat Komolmit; Henry L.Y. Chan; Tawesak Tanwandee; Wattana Sukeepaisarnjaroen; Mário G. Pessoa; Eduardo Fassio; Suzane K. Ono; Fernando Bessone; Jorge Daruich; Stefan Zeuzem; Michael Manns; Alkaz Uddin; Yuhong Dong; Aldo Trylesinski; Prince of Songkla University; Chulalongkorn University; Chinese University of Hong Kong; Mahidol University; Khon Kaen University; Universidade de Sao Paulo - USP; Hospital Nacional Professor Dr. Alejandro Posadas; Universidad Nacional de Rosario; Hospital de Clinicas Jose de San Martin; Klinikum und Fachbereich Medizin Johann Wolfgang Goethe-Universität Frankfurt am Main; Medizinische Hochschule Hannover (MHH); Novartis Pharmaceuticals Corporation; Novartis International AG
1-May-2012Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisisFranck E. Nicolini; Tamas Masszi; Zhixiang Shen; Neil J. Gallagher; Saengsuree Jootar; Bayard L. Powell; Pedro Enrique Dorlhiac-Llacer; Ming Zheng; Tomasz Szczudlo; Anna Turkina; Hopital Edouard Herriot; Szent Laszlo Hospital; Ruijin Hospital; Novartis International AG; Mahidol University; Wake Forest University; Universidade de Sao Paulo - USP; Novartis Pharmaceuticals Corporation; National Research Center for Hematology
1-Jan-2012Expanding Nilotinib Access in Clinical Trials (ENACT): An open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phaseFranck E. Nicolini; Anna Turkina; Zhi Xiang Shen; Neil Gallagher; Saengsuree Jootar; Bayard L. Powell; Carmino De Souza; Ming Zheng; Tomasz Szczudlo; Philipp Le Coutre; Hopital Edouard Herriot; National Research Center for Hematology; Ruijin Hospital; Novartis International AG; Mahidol University; Wake Forest University Baptist Medical Center; Universidade Estadual de Campinas; Novartis Pharmaceuticals Corporation; Charité – Universitätsmedizin Berlin
1-Jan-2014Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2H. S. Rugo; K. I. Pritchard; M. Gnant; S. Noguchi; M. Piccart; G. Hortobagyi; J. Baselga; A. Perez; M. Geberth; T. Csoszi; E. Chouinard; V. Srimuninnimit; P. Puttawibul; J. Eakle; W. Feng; H. Bauly; M. El-hashimy; T. Taran; H. A. Burris; UCSF Helen Diller Family Comprehensive Cancer Center; University of Toronto; Medizinische Universitat Wien; Osaka University; Institut Jules Bordet; University of Texas MD Anderson Cancer Center; Memorial Sloan-Kettering Cancer Center; Memorial Cancer Institute; Praxisklinic am Rosengarten Mannheim; Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz-Rendelointezet; Cambridge Memorial Hospital; Mahidol University; Prince of Songkla University; Novartis Pharmaceuticals Corporation; Novartis Pharma AG; Sarah Cannon Research Institute
1-May-2016Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trialA. Hochhaus; G. Saglio; T. P. Hughes; R. A. Larson; D. W. Kim; S. Issaragrisil; P. D. Le Coutre; G. Etienne; P. E. Dorlhiac-Llacer; R. E. Clark; I. W. Flinn; H. Nakamae; B. Donohue; W. Deng; D. Dalal; H. D. Menssen; H. M. Kantarjian; Universitatsklinikum Jena und Medizinische Fakultat; Università degli Studi di Torino; The University of Adelaide; University of Chicago; The Catholic University of Korea; Mahidol University; Charité – Universitätsmedizin Berlin; Institut Bergonie; Universidade de Sao Paulo - USP; Royal Liverpool and Broadgreen University Hospitals NHS Trust; Sarah Cannon Research Institute; Osaka City University; Novartis Pharmaceuticals Corporation; Novartis International AG; University of Texas MD Anderson Cancer Center
1-Jan-2013Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2Kathleen I. Pritchard; Howard A. Burris; Yoshinori Ito; Hope S. Rugo; Shaker Dakhil; Gabriel N. Hortobagyi; Mario Campone; Tibor Csöszi; José Baselga; Puttisak Puttawibul; Martine Piccart; Daniel Heng; Shinzaburo Noguchi; Vichien Srimuninnimit; Hugues Bourgeois; Antonio Gonzalez Martin; Karen Osborne; Ashok Panneerselvam; Tetiana Taran; Tarek Sahmoud; Michael Gnant; University of Toronto; Sarah Cannon Research Institute; Cancer Institute Hospital of Japan Foundation for Cancer Research; UCSF Helen Diller Family Comprehensive Cancer Center; Cancer Center of Kansas; University of Texas MD Anderson Cancer Center; Centre de Recherche en Cancérologie; Hetenyi Geza County Hospital; Memorial Sloan-Kettering Cancer Center; Prince of Songkla University; Institut Jules Bordet; University of Calgary; Osaka University; Mahidol University; Centre Jean Bernard; MD Anderson Cancer Center, Madrid; Novartis International AG; Novartis Pharmaceuticals Corporation; Medizinische Universitat Wien
1-Apr-2010Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemiasMaria Domenica Cappellini; John Porter; Amal El-Beshlawy; Chi Kong Li; John F. Seymour; Mohsen Elalfy; Norbert Gattermann; Stéphane Giraudier; Jong Wook Lee; Lee Lee Chan; Kai Hsin Lin; Christian Rose; Ali Taher; Swee Lay Thein; Vip Viprakasit; Dany Habr; Gabor Domokos; Bernard Roubert; Antonis Kattamis; Universita degli Studi di Milano; UCL; Cairo University; Prince of Wales Hospital Hong Kong; Peter Maccallum Cancer Centre; Ain Shams University; Heinrich Heine Universitat; Hopital Henri Mondor; The Catholic University of Korea; University of Malaya Medical Centre; National Taiwan University Hospital; Hopital Saint-Vincent-de-Paul; American University of Beirut; King's College London; Mahidol University; Novartis Pharmaceuticals Corporation; Novartis International AG; University of Athens